Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theratechnologies Inc (NQ: THTX ) 1.460 UNCHANGED Streaming Delayed Price Updated: 10:39 AM EDT, Jul 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Theratechnologies Inc < Previous 1 2 3 Next > Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price March 07, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Inc. (NASDAQ:THTX) Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties March 01, 2023 San Diego, CA -- (SBWIRE) -- 03/01/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Theratechnologies Inc. Via SBWire Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022 February 28, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management February 28, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV February 22, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Path to Resume TH1902 Clinical Development February 16, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update February 14, 2023 From Theratechnologies Via GlobeNewswire Theratechnologies Inc. (NASDAQ:THTX) Investor Alert: Investigation over Possible Violations of Securities Laws January 17, 2023 San Diego, CA -- (SBWIRE) -- 01/17/2023 -- An investigation on behalf of investors of Theratechnologies Inc. (NASDAQ:THTX) shares over potential securities laws violations by Theratechnologies Inc. and... Via SBWire Open Letter to Shareholders from CEO Paul Levesque January 04, 2023 Theratechnologies Announces Fiscal Year 2023 Guidance and Operating Plan’s Key Objectives From Theratechnologies Via GlobeNewswire Theratechnologies Announces Update from Ongoing TH1902 Study December 01, 2022 This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,... From Theratechnologies Via GlobeNewswire Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays October 26, 2022 From Theratechnologies Via GlobeNewswire Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update October 13, 2022 From Theratechnologies Via GlobeNewswire Theratechnologies Presents Data Demonstrating High Expression of Sortilin (SORT1) in Multiple Tumor Types at 34th EORTC-NCI-AACR Symposium October 12, 2022 From Theratechnologies Via GlobeNewswire Theratechnologies’ Trogarzo® Approved by FDA for 30-Second Intravenous (IV) Push, Simplifying HIV Treatment for Heavily Treatment-Experienced Population October 03, 2022 From Theratechnologies Via GlobeNewswire Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement July 27, 2022 This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14,... From Theratechnologies Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.